Skip to content

Effects of various dietary fiber intervention strategies on gut microbiota and mental health in healthy adults

Effects of various dietary fiber intervention strategies on gut microbiota and mental health in healthy adults

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400090711
Enrollment
Unknown
Registered
2024-10-12
Start date
2024-10-18
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

MCC Group:Participants in the MCC intervention group will ingest a half dose (25g/day for women and 35g/day for men) of microcrystalline cellulose powder daily before breakfast and before dinner.
AX Group:Participants in the AX intervention group will ingest a half dose (25g/day for women and 35g/day for men) of arabinogalactan powder daily before breakfast and before dinner.
MAX Group:Participants in the MAX intervention group will consume half a dose (25g/day for women and 35g/day for men) of microcrystalline cellulose powder daily before breakfast
and half a dose (25g/day for women and 35g/day for men) of arabinoxylan powder before dinner.

Sponsors

School of Public Health, Xiamen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1.Age: 18-55 years old (adults), gender is not limited; 2.Healthy (no clinically diagnosed mental illness or physical illness that would affect mental health at the time of enrolment); 3.Not pregnant; 4.If you are already using probiotic or prebiotic products, stop using them for at least 4 weeks; 5.Understand the experimental procedures and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Unwillingness to accept informed consent; 2. Pregnant women; 3. Patients with diseases that may affect the project or are not suitable for clinical research; 4. Patients suffering from mental disorders or cognitive disorders; 5. Patients who have participated in other clinical trials within 4 weeks prior to the start of this project.

Design outcomes

Primary

MeasureTime frame
Mental Health Questionnaire;Gut Microbiota;Blood metabolomics;

Secondary

MeasureTime frame
Basic information on demography;Questionnaires on exercise, satiety, gastrointestinal symptoms, faecal pattern and frequency of bowel movements.;Fitbit (sleep );Body composition analysis;Salivary cortisol;Immunological and routine biochemical ;

Countries

China

Contacts

Public ContactChenxi Cai

Xiamen University

chenxicai@xmu.edu.cn+86 592 218 6358

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026